Marina Bárcena-Varela

Dr. Marina Bárcena-Varela


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MBMarina Bárcena-Varela
Marina Bárcena-Varela
LCLeticia Colyn
Leticia Colyn
MAITE FERNANDEZ-BARRENAMAITE FERNANDEZ-BARRENA
MAITE FERNANDEZ-BARRENA
Liver fibrosis is an essential component of chronic liver disease (CLD) and hepatocarcinogenesis. The fibrotic stroma is a consequence of sustained liver damage combined with exacerbated extracellular matrix (ECM) accumulation. In this context, activation of hepatic stellate cells (HSCs) plays a key role in both initiation and perpetuation of fibrogenesis. These cells suffer profound remodeling of gene expression in this process. This review is focused on the epigenetic alterations participating in the transdifferentiation of HSCs from the quiescent to activated state. Recent advances in the field of DNA methylation and post-translational modifications (PTM) of histones (acetylation and methylation) patterns are discussed here, together with altered expression and activity of epigenetic remodelers. We also consider recent advances in translational approaches, including the use of epigenetic marks as biomarkers and the promising antifibrotic properties of epigenetic drugs that are currently being used in patients.

1 April 2019 in Journal of Hepatology
Verified
Journal Article
Closed access
MBMarina Bárcena-Varela
Marina Bárcena-Varela
HPHannah Paish
Hannah Paish
LALaura Alvarez
Laura Alvarez
JOJulen Oyarzabal
Julen Oyarzabal
FPFelipe Prosper
Felipe Prosper
MFMaite G Fernandez-Barrena
Maite G Fernandez-Barrena